{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-030552","form_type":"8-K","ticker":"ARDT","cik":"0001756655","company_name":"Ardent Health, Inc.","filed_at":"2026-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.859096+00:00","generated_at":"2026-05-14T23:29:15.260114+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ardent Health Q1 2026: Revenue $1.60B (+7%), Adjusted EBITDA $124M (+26%), Reaffirms FY Guidance","bullets":["Total revenue $1.602B (+7.0% YoY); net income $40M ($0.28 diluted EPS) vs $41M ($0.29) a year ago.","Adjusted EBITDA $124M (+26.3% YoY); excluding $10.9M gain, growth was 15%.","Adjusted admissions +2.0%, total surgeries +1.2%; admissions -1.1% due to severe weather and light respiratory season.","Reaffirmed FY2026 guidance: revenue $6.4–$6.7B, Adj EBITDA $485–$535M, diluted EPS $0.90–$1.27.","Lease-adjusted net leverage improved to 2.6x from 3.0x a year ago; cash $610M, total debt $1.1B."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-030552","json":"https://secwatch.observer/filing/0001628280-26-030552.json","markdown":"https://secwatch.observer/filing/0001628280-26-030552.md","text":"https://secwatch.observer/filing/0001628280-26-030552.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756655/000162828026030552/0001628280-26-030552-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756655/000162828026030552/ardt-20260505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:29:15.260114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c6a7b0f897507c3d34e9ab40a1daf2cb6fc5a96","claim":"Ardent Health, Inc. reported the first quarter ended March 31, 2026 results: revenue $1,602 million, net income $40 million, EPS $0.28 per diluted share. Guidance reaffirmed.","evidence_excerpt":"period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.60 billion 7.0% growth Y/Y Net Income Attributable to Ardent Health $40 million Adjusted EBITDA (1) $124 million 26.3% growth Y/Y Adjusted EBITDAR (1) $166 million Admissions Decrease of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1756655/000162828026030552/0001628280-26-030552-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2026"},{"label":"Revenue","value":"$1,602 million"},{"label":"Net income","value":"$40 million"},{"label":"EPS","value":"$0.28 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}